This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Volker Geiβ
Introduction
Volker Geiβ is a notable inventor based in Ratingen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating cardiovascular disorders. His work has led to the filing of a patent that showcases his innovative approach to drug development.
Latest Patents
Geiβ holds a patent for "Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof." This patent relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, detailing processes for their preparation and their application in the treatment and prevention of diseases. The focus of this invention is particularly on cardiovascular disorders, highlighting its potential impact on healthcare.
Career Highlights
Throughout his career, Volker Geiβ has been associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to engage in cutting-edge research and development, contributing to advancements in medical treatments.
Collaborations
Geiβ has collaborated with esteemed colleagues such as Ulf Brüggemeier and Chantal Fürstner. These partnerships have fostered a collaborative environment that enhances innovation and drives the development of new therapeutic solutions.
Conclusion
Volker Geiβ's contributions to medicinal chemistry and his innovative patent for cardiovascular treatments underscore his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile